WEBINAR: What Do We Know About Immunity to SARS-CoV-2 and What are the Implications for Public Health Policies?

The Scientific Advisory Group on COVID-19 presents its second report

16.00 h
Virtual (Zoom)
Antoni Plasència, Jaume Padròs, Julià Blanco, Silvia de Sanjosé

The magnitude, quality and durability of immune responses against SARS-CoV-2 will define the epidemiological dynamics of COVID-19 and the strategies put in place to protect individuals and populations.

The Scientific Advisory Group on COVID-19 (Grupo Colaborativo Multidisciplinar para el Seguimiento Científico de la COVID-19, GCMSC), a multidisciplinary group of independent researchers promoted by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation, and the Barcelona Medical Council (COMB), in collaboration with the Catalan Research Centres Association (ACER), presents its second report " What Do We Know About Immunity to SARS-CoV-2 and What are the Implications for Public Health Policies?", where they review the current gaps in knowledge, and the implications in terms of immune protection, vaccination strategies and epidemiological surveillance. 

The webinar will be held in catalan. 



  • Antoni Plasència, ISGlobal General Director. El rol del coneixement científic en el context de la pandèmia COVID-19.
  • Jaume Padrós, CoMB President. El GCMSC, un grup multidisciplinar amb vocació de servei públic.
  • Julià Blanco, IrsiCaixa/IGTP researcher and CGMSC member. Conclusions de l’informe: What do we know about Immunity to SARS-CoV-2? Implication for Public Health Policies.
  • Silvia de Sanjosé, GCMSC Chair and ICO consultant. Futures línies de treball del GCMSC.


The event will be held through Zoom platform. Access the registration form via the following link:





In collaboration with: